GlobalData on MSN16h
Roche secures CE mark for ovarian cancer detection test
Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
360dx13h
Roche IHC Assay Nabs CE Mark as Companion Diagnostic for Abbvie's Elahere in Ovarian Cancer
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
Roche's VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Gets CE Mark In Ovarian Cancer Treatment
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
中国日报网11d
Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification
Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...
FierceBiotech19d
Roche collects more data to support blood tests for diagnosing Alzheimer’s disease
Presented at the Clinical Trials in Alzheimer’s Disease congress, being held in Madrid, Spain, Roche’s diagnostics unit showed that a negative result from one test—its Elecsys amyloid plasma ...
Roche receives CE Mark for Ventana FOLR1 RxDx Assay
Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...
Medical Xpress28d
Roche hikes mpox tests production capacity as virus spreads
Swiss pharmaceutical giant Roche said Wednesday that it was increasing its capacity to produce diagnostic tests to detect mpox, amid a flare-up of the potentially deadly virus. "We've ramped up ...
中国日报网11d
Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification
This not only is a high recognition of Roche Diagnostics' innovative strength but also motivates us to further create sustainable value for patients through a new model and through an 'in China ...